From Janaury 1, 2023 to March 31, 2023, the company has repurchased 1,249,867 shares, for $20.36 million. With this, the company has completed the repurchase of 3,736,668 shares, for $58.66 million under the buyback announced on September 8, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 USD | +0.43% | -0.20% | +3.04% |
2023 | Saba Capital Master Fund, Ltd Issues a Letter to BlackRock Health Sciences Term Trust | CI |
2023 | BlackRock Health Sciences Term Trust authorizes a Buyback Plan. | CI |
1st Jan change | Capi. | |
---|---|---|
+3.04% | 1.6B | |
+5.57% | 12.91B | |
+10.99% | 9.59B | |
+0.55% | 5.64B | |
+5.66% | 5.38B | |
+6.24% | 5.21B | |
+21.04% | 4.69B | |
+19.59% | 4.53B | |
+2.49% | 4.07B | |
+6.97% | 3.87B |
- Stock Market
- Equities
- BMEZ Stock
- News BlackRock Health Sciences Term Trust
- Tranche Update on BlackRock Health Sciences Trust II's Equity Buyback Plan announced on September 8, 2022.